• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过积极切除肝门部胆管癌提高生存率。

Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

作者信息

Baer H U, Stain S C, Dennison A R, Eggers B, Blumgart L H

机构信息

Clinic for Visceral and Transplantation Surgery, University of Berne, Switzerland.

出版信息

Ann Surg. 1993 Jan;217(1):20-7. doi: 10.1097/00000658-199301000-00005.

DOI:10.1097/00000658-199301000-00005
PMID:8380975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1242729/
Abstract

The operative management of hilar cholangiocarcinoma has evolved because of advances in diagnostic imaging that have permitted improved patient selection, and refinements in operative techniques that have lowered operative mortality rates. Over a 4-year period, 48 patients with hilar cholangiocarcinoma were managed. Twenty-seven patients were treated by palliative measures. Preoperative investigation identified 29 patients who were judged fit for operation without proven irresectability by radiologic studies, and 21 of the 29 patients had tumor removal (72%). Twenty-three operative procedures were performed: local excision (n = 12) (two had subsequent hepatic resection), and hepatic resection primarily (n = 9). Eight patients had complications (35%), and one patient died (4.3%). The mean actuarial survival after local excision in 36 months, and after hepatic resection, 32 months. Palliation as assessed by personal interview was excellent for more than 75% of the months of survival. A combination of careful patient selection and complete radiologic assessment will allow an increased proportion of patients to be resected by complex operative procedures with low mortality rate, acceptable morbidity rate, and an increase in survival with an improved quality of life.

摘要

由于诊断性影像学的进展使得患者选择得到改善,以及手术技术的改进降低了手术死亡率,肝门部胆管癌的手术治疗方法不断演变。在4年期间,对48例肝门部胆管癌患者进行了治疗。27例患者接受了姑息治疗。术前检查确定了29例经放射学检查判断适合手术且未证实无法切除的患者,其中21例(72%)接受了肿瘤切除。共进行了23例手术:局部切除(n = 12)(其中2例随后进行了肝切除),主要为肝切除(n = 9)。8例患者出现并发症(35%),1例患者死亡(4.3%)。局部切除后的平均精算生存率为36个月,肝切除后为32个月。通过个人访谈评估,超过75%的生存月数的姑息治疗效果良好。仔细的患者选择和全面的放射学评估相结合,将使更多患者能够通过复杂的手术进行切除,手术死亡率低,发病率可接受,生存率提高,生活质量改善。

相似文献

1
Improvements in survival by aggressive resections of hilar cholangiocarcinoma.通过积极切除肝门部胆管癌提高生存率。
Ann Surg. 1993 Jan;217(1):20-7. doi: 10.1097/00000658-199301000-00005.
2
Management strategies in resection for hilar cholangiocarcinoma.肝门部胆管癌切除术的管理策略
Ann Surg. 1992 Jan;215(1):31-8. doi: 10.1097/00000658-199201000-00005.
3
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
4
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?肝门部胆管癌的积极手术方式:肝切除还是局部切除?
Surgery. 1998 Feb;123(2):131-6.
5
Liver resection for bile duct cancer.胆管癌的肝切除术
Surg Clin North Am. 1989 Apr;69(2):323-37. doi: 10.1016/s0039-6109(16)44789-4.
6
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.影响肝门部胆管癌切除术后发病率、死亡率及生存率的因素。
Ann Surg. 1996 Apr;223(4):384-94. doi: 10.1097/00000658-199604000-00007.
7
Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.肝门部胆管癌的扩大肝切除术:46例患者分析
Arch Surg. 2004 May;139(5):514-23; discussion 523-5. doi: 10.1001/archsurg.139.5.514.
8
Surgical management of hilar cholangiocarcinoma.肝门部胆管癌的外科治疗
Ann Surg. 2005 May;241(5):693-9; discussion 699-702. doi: 10.1097/01.sla.0000160701.38945.82.
9
Surgery for hilar cholangiocarcinoma: the Leeds experience.肝门部胆管癌手术:利兹的经验
Eur J Surg Oncol. 2008 Jul;34(7):787-94. doi: 10.1016/j.ejso.2007.10.005. Epub 2007 Nov 26.
10
Resective operations for biliary carcinoma.胆管癌的切除手术。
Jpn J Surg. 1990 Nov;20(6):613-9. doi: 10.1007/BF02471023.

引用本文的文献

1
Study of ultrasound-guided percutaneous microwave ablation combined with portal vein embolization for rapid future liver remnant increase of planned hepatectomy.超声引导下经皮微波消融联合门静脉栓塞术用于促进计划肝切除术后未来肝脏残余体积快速增加的研究
Front Oncol. 2023 Jan 4;12:926810. doi: 10.3389/fonc.2022.926810. eCollection 2022.
2
Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review.腔内近距离放射治疗在胆管癌胆道梗阻姑息治疗中的作用:简要综述。
World J Gastrointest Endosc. 2022 Mar 16;14(3):106-112. doi: 10.4253/wjge.v14.i3.106.
3
Parenchyma-preserving hepatectomy including segments I + IV resection and bile duct resection in a patient with type IV perihilar cholangiocarcinoma: A case report with video clip.保留实质的肝切除术,包括对一名IV型肝门周围胆管癌患者进行I + IV段切除及胆管切除:病例报告并附视频片段
Ann Hepatobiliary Pancreat Surg. 2021 Aug 31;25(3):419-425. doi: 10.14701/ahbps.2021.25.3.419.
4
Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma.保留实质的肝切除术的标准技术和改良技术,重点在于肝门周围胆管癌患者的Ⅰ+Ⅳ段切除。
Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):112-121. doi: 10.14701/ahbps.2021.25.1.112.
5
Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.我们对肝门部胆管癌启动新辅助化疗的理论依据:关于肝门部胆管癌外科领域“可切除边缘”标准的提议。
World J Surg. 2019 Apr;43(4):1094-1104. doi: 10.1007/s00268-018-04883-y.
6
Brachytherapy in the treatment of bile duct cancer - a tough challenge.近距离放射疗法治疗胆管癌——一项严峻挑战。
J Contemp Brachytherapy. 2017 Apr;9(2):187-195. doi: 10.5114/jcb.2017.66893. Epub 2017 Mar 30.
7
Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer.经肝技术与腔内脉冲剂量率(PDR-BT)近距离放射治疗在局部晚期胆管癌和胰腺癌治疗中的应用
J Contemp Brachytherapy. 2009 Jun;1(2):97-104. Epub 2009 Jul 17.
8
Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments.术前检查中实施LiMAx算法后肝切除术后肝衰竭及相关死亡率的降低:对1170例一个或多个肝段肝切除术的单中心分析
HPB (Oxford). 2015 Jul;17(7):651-8. doi: 10.1111/hpb.12424.
9
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure.肝门部胆管癌:旨在治愈的手术切除范围的争议
Int J Colorectal Dis. 2015 Feb;30(2):159-71. doi: 10.1007/s00384-014-2063-z. Epub 2014 Nov 8.
10
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality.144例肝门部胆管癌的手术治疗,无肝相关死亡病例。
World J Surg. 2014 May;38(5):1164-76. doi: 10.1007/s00268-013-2394-x.

本文引用的文献

1
Carcinoma of the major intrahepatic and the extrahepatic bile ducts exclusive of the papilla of Vater.主要肝内和肝外胆管癌,不包括Vater壶腹。
Surg Gynecol Obstet. 1957 Mar;104(3):357-66.
2
Causes and characteristics of 500 consecutive cases of jaundice.500例连续黄疸病例的病因及特征
Scand J Gastroenterol. 1981;16(1):1-6.
3
Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents.近端胆管肿瘤:采用硅橡胶经肝胆汁支架的手术治疗
Ann Surg. 1982 Oct;196(4):412-9. doi: 10.1097/00000658-198210000-00004.
4
Factors affecting mortality in biliary tract surgery.影响胆道手术死亡率的因素。
Am J Surg. 1981 Jan;141(1):66-72. doi: 10.1016/0002-9610(81)90014-3.
5
Non-surgical biliary drainage.非手术性胆道引流
Clin Gastroenterol. 1983 Jan;12(1):297-316.
6
Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice.胆管引流在梗阻性黄疸中作用的实验与临床研究
Am J Surg. 1981 Aug;142(2):293-9. doi: 10.1016/0002-9610(81)90296-8.
7
Prediction of risk in biliary surgery.胆道手术风险预测。
Br J Surg. 1983 Sep;70(9):535-8. doi: 10.1002/bjs.1800700910.
8
Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial.术前经皮经肝胆道引流:一项对照试验的结果。
Br J Surg. 1984 May;71(5):371-5. doi: 10.1002/bjs.1800710522.
9
Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.高位胆管癌的临床病理特征。手术切除及旁路手术治疗经验。
Ann Surg. 1984 Jun;199(6):623-36. doi: 10.1097/00000658-198406000-00001.
10
Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire.192铱丝胆道引流联合内放疗治疗肝门癌
Br J Surg. 1983 Dec;70(12):733-5. doi: 10.1002/bjs.1800701213.